|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 302.08 DKK | +1.03% |
|
-1.35% | -51.47% |
| 12-08 | Health Care Down Amid Intensified Obesity-Drug Competition - Health Care Roundup | DJ |
| 12-08 | European Equities Traded in the US as ADRs Little Changed in Monday Trading | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 12.97x | 7.04x | 6.79x | 4.66x | 9.64x | 11.15x | 3.89% | 207B | ||
| 43.61x | 32.84x | 0.46x | 14.44x | 32.05x | 34.43x | 0.59% | 893B | ||
| 19.24x | 6.18x | 0.24x | 5.4x | 14.95x | 16.4x | 2.56% | 486B | ||
| 52.12x | -538.68x | 0.66x | 7.39x | 17.51x | 18.01x | 2.92% | 394B | ||
| 18.44x | 6.58x | 0.27x | 4.63x | 11.59x | 13.15x | 3.11% | 336B | ||
| 27.22x | 6.14x | 0.57x | 5.16x | 15.3x | 16.09x | 1.78% | 280B | ||
| 18.22x | 5.71x | 0.81x | 4.93x | 11.59x | 12.49x | 3.1% | 253B | ||
| 12.78x | 4.56x | 0.86x | 4.18x | 8.94x | 10.09x | 3.27% | 246B | ||
| 24.54x | 19.41x | 0.34x | 5.99x | 10.29x | 13.75x | 2.97% | 173B | ||
| 17.68x | 6.63x | 0.01x | 5.58x | 10.21x | 12.27x | 2.73% | 150B | ||
| 13.34x | 1.62x | 0.36x | 2.99x | 7.53x | 8.67x | 6.62% | 147B | ||
| 12.16x | 1.3x | 0.24x | 2.62x | 8.52x | 9.49x | 4.97% | 118B | ||
| 28.46x | 6.01x | -0.03x | 8.6x | 18.57x | 19.29x | -.--% | 112B | ||
| 12.21x | 5.31x | -0.06x | 2.89x | 8.39x | 8.75x | 4.78% | 105B | ||
| 13.14x | 5.1x | 0.11x | 2.69x | 7.93x | 9.09x | 3.57% | 97.31B | ||
| 31.58x | 6.87x | 2.97x | 10.18x | 19.92x | 21.3x | 3.09% | 86.79B | ||
| 188.11x | 67.93x | -0.92x | 14.75x | 97.37x | 94.25x | -.--% | 56.81B | ||
| 47.09x | 6.89x | 1.44x | 11.37x | 37.37x | 39.3x | 0.44% | 58.65B | ||
| 40.05x | 1.02x | 0.64x | 2.44x | 9.01x | 25.91x | 4.49% | 45.17B | ||
| Average | 33.31x | -17.98x | 0.83x | 6.36x | 18.77x | 20.73x | 2.89% | 223.44B | |
| Weighted average by Cap. | 29.95x | -37.86x | 0.78x | 7.38x | 18.17x | 19.78x | 2.52% |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















